Oral contraceptive use and risk of fractures

被引:23
|
作者
Vestergaard, Peter [1 ]
Rejnmark, Lars [1 ]
Mosekilde, Leif [1 ]
机构
[1] Aarhus Univ Hosp, Osteoporosis Clin, Aarhus Amtssygehus, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
关键词
fracture; oral contraceptives; epidemiology; risk factors; confounders;
D O I
10.1016/j.contraception.2006.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors. Subjects and Methods: All women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n = 193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables. Results: In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group. Conclusion: Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [1] ORAL-CONTRACEPTIVE PILL USE AND FRACTURES IN WOMEN - A PROSPECTIVE-STUDY
    COOPER, C
    HANNAFORD, P
    CROFT, P
    KAY, CR
    BONE, 1993, 14 (01) : 41 - 45
  • [2] Third generation oral contraceptive use and cardiovascular risk factors
    Döring, A
    Fröhlich, M
    Löwel, H
    Koenig, W
    ATHEROSCLEROSIS, 2004, 172 (02) : 281 - 286
  • [3] Risk of thromboembolic disease and oral contraceptive use
    Le, MG
    CONTRACEPTION FERTILITE SEXUALITE, 1996, 24 (05): : 378 - 383
  • [4] Use of oral corticosteroids and risk of fractures
    Van Staa, TP
    Leufkens, HGM
    Abenhaim, L
    Zhang, B
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (06) : 993 - 1000
  • [5] ORAL-CONTRACEPTIVE USE AND RISK OF CUTANEOUS MALIGNANT-MELANOMA
    PALMER, JR
    ROSENBERG, L
    STROM, BL
    HARLAP, S
    ZAUBER, AG
    WARSHAUER, ME
    SHAPIRO, S
    CANCER CAUSES & CONTROL, 1992, 3 (06) : 547 - 554
  • [6] Oral contraceptive use and risk of melanoma in premenopausal women
    D Feskanich
    D J Hunter
    W C Willett
    D Spiegelman
    M J Stampfer
    F E Speizer
    G A Colditz
    British Journal of Cancer, 1999, 81 : 918 - 923
  • [7] Oral contraceptive use and risk of melanoma in premenopausal women
    Feskanich, D
    Hunter, DJ
    Willett, WC
    Spiegelman, D
    Stampfer, MJ
    Speizer, FE
    Colditz, GA
    BRITISH JOURNAL OF CANCER, 1999, 81 (05) : 918 - 923
  • [8] Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study
    Reed, B. D.
    Harlow, S. D.
    Legocki, L. J.
    Helmuth, M. E.
    Haefner, H. K.
    Gillespie, B. W.
    Sen, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (13) : 1678 - 1684
  • [9] Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study
    Cervenka, I.
    Mahamat-Saleh, Y.
    Savoye, I.
    Dartois, L.
    Boutron-Ruault, M. C.
    Fournier, A.
    Kvaskoff, M.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (10) : 2390 - 2399
  • [10] Oral contraceptive use in relation to smoking
    Morabia, A
    Bernstein, M
    Bleed, D
    Campana, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (02) : 205 - 209